瓜萎薤白半夏汤联合硝酸甘油治疗冠心病心绞痛的疗效观察

Curative Effect of Guaweixiebai Banxia Decoction Combined with Nitroglycerin on Angina Pectoris ofCoronary Heart Disease

ES评分 0

DOI 10.12208/j.ircm.20220058
刊名
International Research in Chinese Medicine
年,卷(期) 2022, 2(3)
作者
作者单位

武警西藏总队 西藏日喀则 ;

摘要
探究冠心病心绞痛硝酸甘油+瓜萎薤白半夏汤联合治疗效果。方法 文章研究时限2021年3月到2022年8月,共有研究对象60人,随机分组,每组30、对照组单用硝酸甘油;研究组加瓜萎薤白半夏汤,比对疗效。结果 研究组内的心绞痛患者凝血指标优于对照组,6分钟步行距离更长,P<0.05;分别于治疗前后对2组研究对象进行SAQ量表评定,治疗前分值无显著差异,治疗后研究组各指标数值均高于对照组P<0.05;治疗后研究组每周心绞痛发作次数和硝酸甘油用量、单次发作持续时间以及症候积分等指标均优于对照组P<0.05。结论 硝酸甘油+瓜萎薤白半夏汤可以有效控制心绞痛患者的凝血指标,临床综合疗效极高,可推广。
Abstract
Objective To explore the therapeutic effect of nitroglycerin+Guaweixiebai Banxia Decoction on coronary heart disease and angina pectoris. Methods From March 2021 to August 2022, 60 subjects were randomly divided into 30 groups and the control group was given nitroglycerin alone; The research group added Guawei Xiebai Banxia Decoction to compare the efficacy. Results The coagulation indexes of angina patients in the study group were better than those in the control group, and the 6-minute walking distance was longer (P<0.05); Before and after treatment, the subjects in the two groups were assessed with SAQ scale, and there was no significant difference in the scores before treatment. After treatment, the values of each index in the study group were higher than those in the control group (P<0.05); After treatment, the number of angina attacks per week, the dosage of nitroglycerin, the duration of a single attack and the symptom score in the study group were better than those in the control group (P<0.05). Conclusion Nitroglycerin+Guaweixiebai Banxia Decoction can effectively control the coagulation index of patients with angina pectoris, and the clinical comprehensive effect is extremely high, which can be promoted.
关键词
瓜萎薤白半夏汤;硝酸甘油;冠心病;心绞痛;疗效
KeyWord
Guawei Xiebai Pinellia Decoction; glyceryl trinitrate; Coronary heart disease; angina pectoris; curative effect
基金项目
页码 44-46
  • 参考文献
  • 相关文献
  • 引用本文

潘璐*. 瓜萎薤白半夏汤联合硝酸甘油治疗冠心病心绞痛的疗效观察 [J]. 国际中医药研究. 2022; 2; (3). 44 - 46.

  • 文献评论

相关学者

相关机构